We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLG icon
3151
Covenant Logistics
CVLG
$887M
$1.69K ﹤0.01%
+78
New +$1.86K
BDJ icon
3152
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.74B
$1.67K ﹤0.01%
183
GDRX icon
3153
GoodRx Holdings
GDRX
$1.15B
$1.66K ﹤0.01%
+392
New +$1.72K
GBFH
3154
GBank Financial Holdings
GBFH
$303M
$1.61K ﹤0.01%
+41
New +$1.62K
UHG
3155
DELISTED
United Homes Group
UHG
$1.59K ﹤0.01%
386
+384
+19,200% +$1.51K
SNFCA icon
3156
Security National Financial
SNFCA
$247M
$1.59K ﹤0.01%
+192
New +$1.62K
TEAD
3157
Teads Holding Co
TEAD
$61.1M
$1.55K ﹤0.01%
+943
New +$2K
CBNA
3158
Chain Bridge Bancorp
CBNA
$309M
$1.54K ﹤0.01%
+47
New +$1.34K
ARQ icon
3159
Arq
ARQ
$88.4M
$1.53K ﹤0.01%
+214
New +$1.41K
KIDS icon
3160
OrthoPediatrics
KIDS
$589M
$1.52K ﹤0.01%
+82
New +$1.69K
LE icon
3161
Lands' End
LE
$391M
$1.51K ﹤0.01%
+107
New +$1.43K
CNMD icon
3162
CONMED
CNMD
$1.48B
$1.5K ﹤0.01%
32
+6
+23% +$311
NBN icon
3163
Northeast Bank
NBN
$1.15B
$1.5K ﹤0.01%
+15
New +$1.53K
IDR icon
3164
Idaho Strategic Resources
IDR
$524M
$1.49K ﹤0.01%
+44
New +$1.04K
BLFS icon
3165
BioLife Solutions
BLFS
$1.65B
$1.48K ﹤0.01%
58
-27
-32% -$640
ABEO icon
3166
Abeona Therapeutics
ABEO
$399M
$1.47K ﹤0.01%
+279
New +$1.77K
GKOS icon
3167
Glaukos
GKOS
$10B
$1.47K ﹤0.01%
18
-97
-84% -$8.91K
IVVD icon
3168
Invivyd
IVVD
$186M
$1.47K ﹤0.01%
+1,334
New +$1.18K
TTEC icon
3169
TTEC Holdings
TTEC
$127M
$1.47K ﹤0.01%
+436
New +$1.79K
DSGN icon
3170
Design Therapeutics
DSGN
$859M
$1.46K ﹤0.01%
+194
New +$972
GORO icon
3171
Goldgroup Mining Inc.
GORO
$164M
$1.46K ﹤0.01%
1,743
DRUG
3172
Bright Minds Biosciences
DRUG
$789M
$1.46K ﹤0.01%
+24
New +$932
NOTV
3173
DELISTED
Inotiv
NOTV
$1.45K ﹤0.01%
+1,000
New +$1.78K
SVCO
3174
Silvaco Group
SVCO
$285M
$1.45K ﹤0.01%
+268
New +$1.31K
KZIA
3175
Kazia Therapeutics
KZIA
$137M
$1.44K ﹤0.01%
200

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.